EDGAR Filing Documents for 0001203944-09-000003

Form 8-K - Current report:

SEC Accession No. 0001203944-09-000003

Filing Date

2009-01-05

Accepted

2009-01-05 17:00:41

Documents

Period of Report

2008-12-31

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	RAPTOR FORM 8-K 010509	raptor8k010509.htm	8-K	33096
2	10.1 STARR AMENDMENT	starramendment.htm	EX-10	27868
3	10.2 TSUCHIMOTO AMENDMENT	tsuchimotoamendment.htm	EX-10	27595
4	10.3 ZANKEL AMENDMENT	zankelamendment.htm	EX-10	27768
5	10.4 DALEY AMENDMENT	daleyamendment.htm	EX-10	17322
	Complete submission text file	0001203944-09-000003.txt		135467

Mailing Address 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949

Business Address 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949 415-382-1390

RAPTOR PHARMACEUTICALS CORP. (Filer) CIK: 0001203944 (see all company filings)

IRS No.: 980379351 | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-50720 | Film No.: 09506251
SIC: 2834 Pharmaceutical Preparations